January 04, 2023
15 min listen
Save
Dr. Mali's Top 5 Predictions in Ophthalmology for 2023
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this episode, I share my top five predictions for 2023 in the field of ophthalmology.
Brought to you by Alcon
- Welcome to another exciting episode of Eye Care insider :52
- My review of the top five predictions in ophthalmology 1:03
- Prediction #1 – Vabysmo and anti-VEGF market 1:53
- Prediction #2 – FDA approval for GA treatment 4:26
- Prediction #3 – SNAPS eye shield for ocular protection 6:06
- Prediction #4 – biosimilars and the ophthalmic therapeutic marketplace 10:08
- Prediction #5 – retina analytical tools 12:27
- Thanks for listening 14:30
We’d love to hear from you! Send your comments/questions to Dr. Mali at eyecareinsider@healio.com. Follow us on Twitter @Healio_OSN.
Published by:
Sources/Disclosures
Collapse
Disclosures:
Mali reports he is founder and CEO of Mali Enterprises; retina medical director at Macular Degeneration Association; consultant/speaker for Genentech and Roche; equity owner for SNAPS; and grant/consultant for RetinAI.